FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023

Aug 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-08-07

Reporting Person: Haigh Adrian (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-07	Stock Option	$8.03	A	200000	Acquired	2033-08-07	Common Shares (200000)	Direct

Footnotes

F1: On August 7, 2023, Adrian Haigh was granted a stock option to purchase 200,000 shares of the issuer's common shares pursuant to the issuers 2020 Euity Incentive Plan.

F2: One-third of grant will vest upon the first anniversary date of the grant. On the last day of each successive month, one-twenty fourth of the grant shall vest such that vesting is complete as of third anniversary of grant date.